• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Procure Disaster Recovery Strategy ETF
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

150.57 -6.02 (-3.84%)
Delayed Quote Updated: 4:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,587,288
Open 156.27
Bid (Size) 149.59 (100)
Ask (Size) 175.00 (100)
Prev. Close 156.59
Today's Range 150.24 - 158.25
52wk Range 122.14 - 186.12
Shares Outstanding 101,300,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Neurocrine (NBIX) Q3 2026 Earnings Call Transcript ↗
November 02, 2026
Record $1.1B revenue marks transformative quarter for diversified biotech. 
Via The Motley Fool
Topics Earnings
News headline image
Neurocrine Biosciences Q3 Earnings Call Highlights ↗
November 02, 2026
Neurocrine Biosciences (NASDAQ:NBIX) reported record third-quarter net product sales exceeding $1.1 billion and record operating profitability, supported by growth across its three marketed medicines:... 
Via MarketBeat
Topics Earnings

Performance

52-Week Range 19.1% below 52-week high
150.57
122.1452W Low 186.1252W High
1 Week 10.7% below 1-week high
150.241W Low 168.621W High

Neurocrine Biosciences, Inc. - Common Stock (NBIX) traded between $122.14 and $186.12 over the past 52 weeks and last traded at $150.57, 19.1% below its 52-week high. Over the past week it ranged between $150.24 and $168.62.

Past 12 Months
-8.9%
+6.6%
-1.3%
-3.9%
+7.1%
+8.3%
1W -$14.74
1M +$9.26
3M -$2.00
6M -$6.13
YTD +$9.97
1Y +$11.59

NBIX was +8.3% over the past year, -3.9% over six months, +7.1% year to date, -8.9% in the last week.

12 Months vs Market
NBIX
+8.3%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%

Over the past 12 months NBIX returned +8.3% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 1.19× 3-mo avg
Today 1,587,288 3-mo avg 1.3M
1W
1.4M
1M
1.5M
3M
1.3M
6M
1.3M
YTD
1.2M
1Y
1.2M

NBIX most recently traded 1,587,288 shares against a 3-month average daily volume of 1.3M.

More News

Read More
Neurocrine Biosciences (NASDAQ:NBIX) Q3 Earnings Beat as INGREZZA Guidance Raised ↗
November 02, 2026
Via Chartmill
Topics Earnings
After-Hours Gainers and Losers: Nov. 2, 2026 Postmarket Review ↗
November 02, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX): A Debt-Free GARP Stock With Reasonable Growth ↗
November 02, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX): Affordable Growth at a Reasonable Valuation ↗
October 28, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX) Stands Out as a Decent Value Stock ↗
October 05, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX): Affordable Growth at a Reasonable Valuation ↗
October 02, 2026
Via Chartmill
News headline image
Where Will Neurocrine Biosciences Be in 5 Years? ↗
October 25, 2026
Via The Motley Fool
News headline image
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
October 21, 2026
From FN Media
Via GlobeNewswire
News headline image
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
October 21, 2026
Via FinancialNewsMedia
Neurocrine Biosciences (NASDAQ:NBIX): An Affordable Growth Stock With Strong Momentum and Valuation ↗
August 29, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX): A Value Stock With Quality Behind the Discount ↗
August 05, 2026
Via Chartmill
News headline image
Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit ↗
September 23, 2026
Via MarketBeat
Topics Artificial Intelligence
News headline image
Neurocrine (NBIX) Q2 2026 Earnings Call Transcript ↗
August 03, 2026
Via The Motley Fool
Topics Earnings
News headline image
Neurocrine Biosciences Q2 Earnings Call Highlights ↗
July 31, 2026
Via MarketBeat
Topics Earnings
Neurocrine Biosciences (NASDAQ:NBIX): Strong Growth Stock with Technical Breakout Setup ↗
July 27, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX) Screens as a High Growth Stock ↗
July 25, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX) Offers a High Growth Momentum Breakout Setup ↗
July 20, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX) Fits the Growth at a Reasonable Price Mold of Peter Lynch Screening ↗
July 16, 2026
Via Chartmill
News headline image
Neurocrine (NBIX) Q2 2026 Earnings Call Transcript ↗
July 30, 2026
Via The Motley Fool
Topics Earnings
Neurocrine Biosciences Inc (NASDAQ:NBIX) Scores High in Affordable Growth Screen ↗
July 11, 2026
Via Chartmill
Neurocrine Biosciences Inc (NASDAQ:NBIX) Shines in the "Little Book That Makes You Rich" Screen ↗
July 04, 2026
Via Chartmill
Neurocrine Biosciences Inc (NASDAQ:NBIX) Shows Strong Growth and Technical Breakout Setup ↗
July 01, 2026
Via Chartmill
Neurocrine Biosciences (NASDAQ:NBIX) Fits the Profile of a Classic GARP Stock Under the Peter Lynch Framework ↗
June 24, 2026
Via Chartmill

Frequently Asked Questions

Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?
Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?
Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?
The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market
What is the current price of Neurocrine Biosciences, Inc. - Common Stock?
The current price of Neurocrine Biosciences, Inc. - Common Stock is 150.57
When was Neurocrine Biosciences, Inc. - Common Stock last traded?
The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?
The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 15.25B
How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?
Neurocrine Biosciences, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap